Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, a… Read more
Medios AG (MEDOF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.057x
Based on the latest financial reports, Medios AG (MEDOF) has a cash flow conversion efficiency ratio of 0.057x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($29.30 Million) by net assets ($518.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medios AG - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Medios AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medios AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medios AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The ODP Corporation
MX:ODP
|
0.109x |
|
DroneShield Limited
PINK:DRSHF
|
-0.028x |
|
Farmland Partners Inc
NYSE:FPI
|
-0.003x |
|
Varex Imaging Corp
NASDAQ:VREX
|
-0.033x |
|
Retailors Ltd
PINK:RTALF
|
-0.047x |
|
Distoken Acquisition Corporation Right
NASDAQ:DISTR
|
N/A |
|
Dark Horse Beijing Technology Co Ltd
SHE:300688
|
-0.034x |
|
First Tractor Company Limited
PINK:FIRRF
|
0.107x |
Annual Cash Flow Conversion Efficiency for Medios AG (2010–2024)
The table below shows the annual cash flow conversion efficiency of Medios AG from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $510.19 Million | $73.67 Million | 0.144x | +312.59% |
| 2023-12-31 | $468.81 Million | $16.41 Million | 0.035x | -57.76% |
| 2022-12-31 | $448.05 Million | $37.12 Million | 0.083x | -46.92% |
| 2021-12-31 | $394.16 Million | $61.52 Million | 0.156x | +158.32% |
| 2020-12-31 | $142.43 Million | $-38.12 Million | -0.268x | -4762.04% |
| 2019-12-31 | $81.63 Million | $-449.29K | -0.006x | +87.62% |
| 2018-12-31 | $70.50 Million | $-3.14 Million | -0.044x | -348.97% |
| 2017-12-31 | $45.68 Million | $816.00K | 0.018x | +138.51% |
| 2016-12-31 | $34.10 Million | $-1.58 Million | -0.046x | +84.92% |
| 2015-12-31 | $323.78K | $-99.64K | -0.308x | -- |
| 2014-12-31 | $0.00 | $13.30K | x | -- |
| 2013-12-31 | $7.81K | $103.36K | 13.241x | +10691.51% |
| 2012-12-31 | $172.97K | $21.22K | 0.123x | +157.35% |
| 2011-12-31 | $376.75K | $-80.60K | -0.214x | -1872.06% |
| 2010-12-31 | $341.07K | $-3.70K | -0.011x | -- |